Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Chait

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Atherosclerosis|February 22, 2005
Ex vivo measures of LDL oxidative susceptibility predict carotid artery diseaseAudrey Hendrickson, Laura A McKinstry, Julieann K Lewis, et al.
The American Journal of Cardiology|February 5, 2004
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)Xue-Qiao Zhao, Josh S Morse, Alice A Dowdy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient miceSavitha Subramanian, Chang Yeop Han, Tsuyoshi Chiba, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2012
Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient miceYilei Ding, Savitha Subramanian, Vince N Montes, et al.
The Journal of Biological Chemistry|February 22, 2012
Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrixMary Y Chang, Christina K Chan, Kathleen R Braun, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 6, 2008
Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistanceFrancis Kim, Matilda Pham, Ezekiel Maloney, et al.
The American Journal of Cardiology|November 26, 2009
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)Xue-Qiao Zhao, Richard A Krasuski, Jefferson Baer, et al.
Journal of Lipid Research|September 8, 2012
Inhibition of intestinal cholesterol absorption decreases atherosclerosis but not adipose tissue inflammationTomio Umemoto, Savitha Subramanian, Yilei Ding, et al.
Journal of Diabetes and Its Complications|September 9, 2020
Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjectsDiego Gomes Kjerulf, Shari Wang, Mohamed Omer, et al.
Circulation|May 8, 2002
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetesRobert H Eckel, Momtaz Wassef, Alan Chait, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Atherosclerosis|February 22, 2005
Ex vivo measures of LDL oxidative susceptibility predict carotid artery diseaseAudrey Hendrickson, Laura A McKinstry, Julieann K Lewis, et al.
The American Journal of Cardiology|February 5, 2004
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)Xue-Qiao Zhao, Josh S Morse, Alice A Dowdy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient miceSavitha Subramanian, Chang Yeop Han, Tsuyoshi Chiba, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2012
Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient miceYilei Ding, Savitha Subramanian, Vince N Montes, et al.
The Journal of Biological Chemistry|February 22, 2012
Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrixMary Y Chang, Christina K Chan, Kathleen R Braun, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 6, 2008
Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistanceFrancis Kim, Matilda Pham, Ezekiel Maloney, et al.
The American Journal of Cardiology|November 26, 2009
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)Xue-Qiao Zhao, Richard A Krasuski, Jefferson Baer, et al.
Journal of Lipid Research|September 8, 2012
Inhibition of intestinal cholesterol absorption decreases atherosclerosis but not adipose tissue inflammationTomio Umemoto, Savitha Subramanian, Yilei Ding, et al.
Journal of Diabetes and Its Complications|September 9, 2020
Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjectsDiego Gomes Kjerulf, Shari Wang, Mohamed Omer, et al.
Circulation|May 8, 2002
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetesRobert H Eckel, Momtaz Wassef, Alan Chait, et al.
Pageof 12